Drug safety during breastfeeding: Corticosteroids;Valutazione dei farmaci in corso di allattamento al seno: I corticosteroidi

Medico e Bambino

Volumn 26, Issue 8, 2007, Pages 527-530

  Davanzo, Riccardo ^a   Roncoroni, Ippolita ^b   Rubert, Laura ^c   Oretti, Chiara ^c  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b Pediatra di Famiglia   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Breastfeeding mother; Corticosteroids; Meta variability; Nursing infant

Indexed keywords

BECLOMETASONE; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CORTISONE ACETATE; DEFLAZACORT; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE; METHYLPREDNISOLONE; MOMETASONE FUROATE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE ACETONIDE;

BREAST FEEDING; BREAST FEEDING EDUCATION; DRUG RESEARCH; DRUG SAFETY; HUMAN; MATERNAL CARE; REVIEW;

EID: 35948954353     PISSN: 15913090     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. American Academy of Pediatrics. Committee on Drugs, The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108:776-89.
2. Briggs et al. Drugs in Pregnancy and Lactation. 7th Ed. Lippincott, Williams and Wilkins, 2005.
3. AIFA: Agenzia Italiana del Farmaco. Guida all'uso dei farmaci, sulla base del British National Formulary 2005.
4. Hale W. Medications and mother's milk. 13a edizione, 2006.
5. Hardman JG, Limbird LE. Goodman & Gilman's The pharmacological basis of therapeutics. Tenth Edition. New York: McGraw-Hill, 2001.
6. Anderson PO. Corticosteroids use by breast-feeding mothers. Clin Pharm 1987;6:445.
7. Berlin CM, Kaiser DG, Demers L. Excretion of prednisone in human milk. Pharmacologist 1979;21:264.
8. Greenberger PA, Odeh YK, Frederiksen MC, Atkinson AJ jr. Pharmacokinetics of prednisolone transfer to breastmilk. Clin Pharmacol Ther 1993;53:324-8.
9. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8(3):209.
10. Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal 2000;83:F177-81.
11. Kutschera J, Tomaselli J, Maurer U, Mueller W, Urlesberger B. Minor neurological dysfunction, cognitive development and somatic development at the age of 3 to 7 years after dexamethasone treatment in very-low birth-weight infants. Early Human Development 2005;81:281-7.
12. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexametasone treatment in extremely low birth weight infants. N Engl J Med 2001;344:95-101.
13. Hale TW, Berens PD. Clinical Therapy in Breastfeeding patients. 2nd Ediztion. Pharmasoft Medical Publishing, Amarillo, TX, 2002.
14. Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M. Pharmacokinetics and oral bioavaibility of hidrocortisone. J Clin Pharmacol 1991;31(5):473-6.
15. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998:339(5):285-91.
16. Vukusic S. Confavreux C. Pregancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg 2006;108:266-70. Epub 2006 Jan 4.
17. Gulick EE, Johnson S. Infant health of mothers with multiple sclerosis. West J Nurs Res 2004;26(6):632-49.
18. Lawrence RA, Lawrence RM. Rheumatoid arthritis and other connective tissue disorders. In: Breastfeeding. A guide for the medical profession. 6th Edition. Elsevier Mosby, 2005.
19. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses'Health Study. Arthritis Rheum 2004;50(11):3458-67.
20. Barrett JH, Brennan P, Fiddler M, Silman A. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. J Gend Specif Med 2002;5(4):28-37.